Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows. These include CAD/CAM-compatible components, digital prosthetics, and software and scanning technologies designed to integrate clinical and laboratory processes. The company also supplies adjunctive tools and instruments, clinical training, and technical support aimed at improving treatment predictability and practice efficiency.
Headquartered in Basel, Switzerland, Straumann serves a global customer base of dental clinicians, laboratories and distributors across Europe, the Americas and the Asia-Pacific region. The company emphasizes research and development, clinical evidence and partnerships with academic and clinical institutions to advance implantology and restorative dentistry. Straumann’s products and services are positioned to address trends toward digital workflows, minimally invasive procedures and comprehensive restorative care.
Straumann is publicly traded and its securities trade internationally, including via the OTC market under the symbol SAUHY. The company’s strategic focus remains on innovation, expanding clinical education and broadening its product portfolio to support dental professionals and improve patient outcomes worldwide.
AI Generated. May Contain Errors.
